Julia Chifman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Julia Chifman

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Frontiers in Immunology|March 3, 2020

Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor TypesEric D Routh, Ashok K Pullikuth, Guangxu Jin, et al.

Journal of Translational Medicine|November 20, 2024

A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancersLaurel K Berry, Ashok K Pullikuth, Kristen L Stearns, et al.

Plos Computational Biology|February 7, 2017

Activated Oncogenic Pathway Modifies Iron Network in Breast Epithelial Cells: A Dynamic Modeling PerspectiveJulia Chifman, Seda Arat, Zhiyong Deng, et al.

Cancer Immunology Research|May 20, 2016

Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune ResponsivenessLance D Miller, Jeff A Chou, Michael A Black, et al.

Frontiers in Oncology|December 27, 2021

Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor OutcomesAshok K Pullikuth, Eric D Routh, Kip D Zimmerman, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Frontiers in Immunology|March 3, 2020

Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor TypesEric D Routh, Ashok K Pullikuth, Guangxu Jin, et al.

Journal of Translational Medicine|November 20, 2024

A patient stratification signature mirrors the immunogenic potential of high grade serous ovarian cancersLaurel K Berry, Ashok K Pullikuth, Kristen L Stearns, et al.

Plos Computational Biology|February 7, 2017

Activated Oncogenic Pathway Modifies Iron Network in Breast Epithelial Cells: A Dynamic Modeling PerspectiveJulia Chifman, Seda Arat, Zhiyong Deng, et al.

Cancer Immunology Research|May 20, 2016

Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune ResponsivenessLance D Miller, Jeff A Chou, Michael A Black, et al.

Frontiers in Oncology|December 27, 2021

Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor OutcomesAshok K Pullikuth, Eric D Routh, Kip D Zimmerman, et al.

Pageof 2